Changes in Beneficial Ownership · 4
Caring Brands, Inc.
CABRNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-10-06
- Issuer
- Caring Brands, Inc.
- Issuer CIK
- 0002020737
- Trading symbol
- CABR
Reporting owner 1
- Name
- WILSON GLYNN
- Reporting owner CIK
- 0001405625
- Relationship
- Director · Officer
- Officer title
- Chief Executive Officer
- Address
- C/O CARING BRANDS, INC., 130 S INDIAN, RIVER DRIVE, SUITE 202 PBM# 1232, FORT PIERCE, FL, 34950
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | 1.13 | 2026-10-06[F1] | A · Form 4 | 75,000 | A | 0 | [F2] | 2031-10-06 | Common Stock | 75,000 | 747,592[F3] | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- On October 6, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan.↩ 1
- F2
- The options vested immediately on October 6, 2026.↩ 1
- F3
- The number of shares of common stock beneficially owned following the reported transaction also includes the Reporting Person's ownership of (i) 126,720 restricted stock units of common stock of the Issuer of which zero have vested, (ii) 45,872 restricted stock units of common stock of the Issuer of which zero have vested, and (iii) 500,000 shares of common stock.↩ 1
Signature 1
- Signed
- /s/ Dr. Glynn Wilson
- Date
- 2026-10-15
Company context
We are a wellness consumer products company. We offer several over-the-counter (OTC) and cosmetic consumer products. Our product pipeline includes a diverse range of products, such as hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, a jellyfish sting protective suncare line, and women’s sexual wellness products, catering to diverse health and wellness needs. Our method of operation ensures that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical trials, (3) products are protected by issued and filed patents, and (4) products have acceptable commercial stability.
Current securities
Recent company filings
- S-1 filingOct 27, 2026
- Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearOct 22, 2026
- 4 filingSep 30, 2026
- 4 filingSep 30, 2026
- Entry into a Material Definitive Agreement · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 22, 2026